Epidiolex maker GW Pharma reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.
Search Results
Keywords: "United Kingdom"
WHO cannabis recommendations still face uphill battle for adoption
The World Health Organization’s cannabis scheduling recommendations appeared to have limited support at a United Nations Commission on Narcotic Drugs (CND) “intersessional” meeting on Thursday in Vienna.
Cannabis opportunities growing in these five international markets
These five countries, which span from Europe to Latin America and Oceania, are worth keeping tabs on for their potential business opportunities down the road.
From Israel to Australia, countries with medical marijuana programs are generating revenue
It turns out there are some healthy, and growing, medical marijuana markets outside the United States and Canada – assuming you can look past the cannabis industry fan fiction.
Global Retreat: Canadian cannabis firms pull back global aspirations
Back in the early days of Canada’s regulated adult-use cannabis industry, some of the country’s biggest publicly traded marijuana producers discovered that investors rewarded international ambitions.
Chile health authority warns of ‘counterfeit’ cannabis medicines
The Public Health Institute of Chile (ISP) issued a warning recently about CBD products offered for sale online without a required sanitary registration.
